7 pending office actions • 2 clients
| Client (Assignee) | Pending OAs |
|---|---|
| Poseida Therapeutics, Inc. | 5 |
| Genentech, Inc. | 2 |
| App # | Title | Client | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|---|
| 19285781 | COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS | Genentech, Inc. | WEN, SHARON X | 1641 | Non-Final OA | Jul 30, 2025 |
| 18264782 | GENETICALLY MODIFIED INDUCED PLURIPOTENT STEM CELLS AND METHODS OF USE THEREOF | Poseida Therapeutics, Inc. | GOMEZ RODRIGUEZ, JULIO WASHINGTON | 1637 | Non-Final OA | Aug 09, 2023 |
| 18351442 | COMPOSITIONS AND METHODS FOR SELECTIVE ELIMINATION AND REPLACEMENT OF HEMATOPOIETIC STEM CELLS | Poseida Therapeutics, Inc. | CARTER, SANDRA DILLAHUNT | 1674 | Non-Final OA | Jul 12, 2023 |
| 17996021 | COMPOSITIONS AND METHODS FOR USE IN THE TREATMENT OF CANCER | Poseida Therapeutics, Inc. | WEHBE, ANNE MARIE SABRINA | 1634 | Non-Final OA | Jun 16, 2023 |
| 18334531 | METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND TIGIT INHIBITORS | Genentech, Inc. | OUSPENSKI, ILIA I | 1644 | Non-Final OA | Jun 14, 2023 |
| 18051109 | HYPERACTIVE PIGGYBAC TRANSPOSASES | Poseida Therapeutics, Inc. | NOAKES, SUZANNE MARIE | 1656 | Non-Final OA | Oct 31, 2022 |
| 16977547 | CARTYRIN COMPOSITIONS AND METHODS FOR USE | Poseida Therapeutics, Inc. | ALLEN, MICHAEL D | 1671 | Final Rejection | Sep 02, 2020 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial